Dr. Richard Isaacson, United States
November 26, 2021
What is the Alzheimer’s disease Assessment
Scale–Cognitive Subscale endpoint and what does it assess? Watch Dr. Richard Isaacson discuss the ADAS-Cog in Alzheimer’s clinical trials.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.